US Patent Issued to Janssen Biotech on May 26 for "Trispecific antibody targeting BCMA, GPRC5D, and CD3" (American, Belgian Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,509, issued on May 26, was assigned to Janssen Biotech Inc. (Horsham, Pa.).

"Trispecific antibody targeting BCMA, GPRC5D, and CD3" was invented by Ricardo Marcos Attar (Spring House, Pa.), Scott Ronald Brodeur (New Hope, Pa.), Rajkumar Ganesan (Thousand Oaks, Calif.), Leopoldo Luistro (Lansdale, Pa.), Ulrike Philippar (Antwerp, Belgium), Kodandaram Pillarisetti (King of Prussia, Pa.), Sanjaya Singh (Blue Bell, Pa.) and Danlin Dan Qing Yang (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are multispecific antibodies that bind to BCMA, GPRC5D and CD3 and multispecific antigen-binding fragments thereof. Also described are re...